CVI Holdings’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

CVI Holdings’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-208,074	Closed	-$524K	–	134
2020 Q2	$524K	Hold	208,074	–	–	0.19%	46
2020 Q1	$266K	Buy	+208,074	New	+$425K	0.93%	19

CVI Holdings's TTPH Position: Q3 2020 in Review

CVI Holdings sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2020, closing a stake of 208,074 shares — an estimated $524K sold.

CVI Holdings first reported a position in TTPH in Q1 2020 and held it in 2 quarters. The position peaked at $524K in Q2 2020. 1 fund tracked by Wall St. Rank holds TTPH as of Q3 2020.

CVI Holdings reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
CVI Holdings sold 208,074 Tetraphase Pharmaceuticals, Inc. shares in Q3 2020, an estimated $524K.
CVI Holdings first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2020 and held it in 2 quarters.
CVI Holdings's Tetraphase Pharmaceuticals, Inc. position peaked at $524K in Q2 2020.
1 fund tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2020.

Based on CVI Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.